Frankfurt for 2013 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Frankfurt for 2013


Next year will see CPhI Worldwide and its collocated events, ICSE, P-MEC and InnoPack return to Frankfurt (Germany). The event is due to take place at the Messe Frankfurt on 22–24 October so keep the dates free!

Frankfurt first hosted CPhI in 1990; indeed, it was the location of the first ever CPhI trade show, attracting 16 exhibitors and 250 delegates as a specialist event dedicated to ingredients and intermediates. Frankfurt has been a regular venue for the show ever since and last played host to CPhI in 2011. The 2011 event was a record year for the organisers with 2,200 exhibitors and around 29,920 attendees.

“We experienced a phenomenal response to the 2011 events and this has influenced our decision to return to Messe Frankfurt in 2013,” said UBM Live Pharma Portfolio Director Greg Kerwin, in a statement. “Frankfurt has traditionally been one of the most popular venues in the events’ 22 year history, not only as a result of it being located in one of Europe’s largest pharmaceutical hubs, but due to its international accessibility, quality and availability of accommodation, and the high standards of service offered by the venue.”

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
20%
Attracting a skilled workforce
28%
Obtaining/maintaining adequate financing
12%
Regulatory compliance
40%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans

Click here